The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
First clinical comparison of Nobori –Biolimus A9 eluting stents with Cypher– Sirolimus eluting stents: NOBORI CORE nine months angiographic and one year clinical outcomes
Miodrag Ostojic1*, MD, PhD; Dragan Sagic2, MD, PhD; Branko Beleslin1, MD, PhD; Robert Jung3, MD, PhD; Zoran Perisic4, MD, PhD; Nikola Jagic5, MD, PhD; Milan Nedeljkovic1, MD, PhD; Ljupco Mangovski2, MD; Bratislav Milosavljevic2, MD; Sinisa Stojkovic1, MD, PhD; Dejan Orlic1, MD, PhD; Zelimir Antonic2, MD; Vladimir Miloradovic5, MD; Dragan Topic2, MD; Dragica Paunovic6, MD; for the NOBORI CORE Investigators
1. Clinical Centre of Serbia, Belgrade, Serbia; 2. Institute for Cardiovascular Disease Dedinje, Belgrade, Serbia; 3. Institute for Cardiovascular Disease Sremska Kamenica, Serbia; 4. Clinical Centre Nis, Nis, Serbia; 5. Clinical Centre Kragujevac, Serbia
Aim: To compare clinical efficacy and safety of stents eluting limus drugs from biodegradable polymer – Nobori, or durable polymer – Cypher.